Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry"

Ann Rheum Dis. 2023 Aug;82(8):e177. doi: 10.1136/annrheumdis-2021-221146. Epub 2021 Aug 13.
No abstract available

Keywords: COVID-19; antirheumatic agents; therapeutics.

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Biological Products* / therapeutic use
  • COVID-19*
  • Humans
  • Registries
  • Rheumatology*

Substances

  • Antirheumatic Agents
  • Biological Products